ADVERTISEMENT
New Drug Combo for ALS Slows Decline in Small Clinical Study
New Drug Combo for ALS Slows Decline in Small Clinical Study
After six months, patients with fast-progressing amyotrophic lateral sclerosis who had received the experimental treatment had less loss of function than those who received a placebo.
New Drug Combo for ALS Slows Decline in Small Clinical Study
New Drug Combo for ALS Slows Decline in Small Clinical Study

After six months, patients with fast-progressing amyotrophic lateral sclerosis who had received the experimental treatment had less loss of function than those who received a placebo.

After six months, patients with fast-progressing amyotrophic lateral sclerosis who had received the experimental treatment had less loss of function than those who received a placebo.

clinical trials, drug development, industry

Desperately Seeking Shut-Eye
Anna Azvolinsky | Mar 1, 2016 | 7 min read
New insomnia drugs are coming on the market, but drug-free therapy remains the most durable treatment.
The Sounds of Silence
Jenny Rood | Sep 1, 2015 | 8 min read
Science-based tinnitus therapeutics are finally coming into their own.
LabCorp Buys CRO
Kerry Grens | Nov 4, 2014 | 1 min read
The $6 billion deal marks yet another massive transaction in the health-care industry.
Pharma Whistleblower
Cristina Luiggi | Aug 16, 2012 | 1 min read
A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.
Best in Industry, 2012
The Scientist | Jun 1, 2012 | 1 min read
Whether working for a pharmaceutical giant or a biotech start-up with a unique vision, researchers who responded to this year’s Best Places to Work in Industry survey are translating society’s most pressing scientific needs into a new generation of drugs, research tools, and cutting-edge innovations.
Best Places to Work Industry, 2012
The Scientist | Jun 1, 2012 | 10+ min read
Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.
ADVERTISEMENT